Literature DB >> 20546781

Cardiovascular risk factors regulate the expression of vascular endothelin receptors.

Cang-Bao Xu1, Yang Sun, Lars Edvinsson.   

Abstract

Cardiovascular disease remains as the leading cause of death in the developed world. However, there is limited knowledge about how cardiovascular risk factors actually cause vascular disease. Traditional cardiovascular risk factors include increased circulating levels of low-density lipoproteins, cigarette smoking and hypertension (both strongly related to arterial wall injury), inflammation and atherosclerosis. The vascular endothelin receptors are a protein family that belongs to the larger family of G-protein coupled receptors. They mediate vascular smooth muscle contraction, proliferation and apoptosis, which are important events in the pathogenesis of atherosclerotic vascular disease. Recent investigations into intracellular signaling mechanisms suggest that the above risk factors increase the expression of endothelin receptors in vascular smooth muscle cells by activating intracellular mitogen-activated protein kinase pathways and downstream transcription factors such as nuclear factor-kappaB. Understanding the mechanisms involved in vascular endothelin receptor upregulation during cardiovascular disease may provide novel therapeutic approaches. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20546781     DOI: 10.1016/j.pharmthera.2010.04.013

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  6 in total

Review 1.  Vascular plasticity in cerebrovascular disorders.

Authors:  Lars I H Edvinsson; Gro Klitgaard Povlsen
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-11       Impact factor: 6.200

2.  Common variant near the endothelin receptor type A (EDNRA) gene is associated with intracranial aneurysm risk.

Authors:  Katsuhito Yasuno; Mehmet Bakırcıoğlu; Siew-Kee Low; Kaya Bilgüvar; Emília Gaál; Ynte M Ruigrok; Mika Niemelä; Akira Hata; Philippe Bijlenga; Hidetoshi Kasuya; Juha E Jääskeläinen; Dietmar Krex; Georg Auburger; Matthias Simon; Boris Krischek; Ali K Ozturk; Shrikant Mane; Gabriel J E Rinkel; Helmuth Steinmetz; Juha Hernesniemi; Karl Schaller; Hitoshi Zembutsu; Ituro Inoue; Aarno Palotie; François Cambien; Yusuke Nakamura; Richard P Lifton; Murat Günel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-21       Impact factor: 11.205

3.  Increased cerebrovascular sensitivity to endothelin-1 in a rat model of obstructive sleep apnea: a role for endothelin receptor B.

Authors:  David J Durgan; Randy F Crossland; Eric E Lloyd; Sharon C Phillips; Robert M Bryan
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-26       Impact factor: 6.200

4.  The N-glycoform of sRAGE is the key determinant for its therapeutic efficacy to attenuate injury-elicited arterial inflammation and neointimal growth.

Authors:  Hyun-Jin Tae; Ji Min Kim; Sungha Park; Noboru Tomiya; Geng Li; Wen Wei; Natalia Petrashevskaya; Ismayil Ahmet; John Pang; Stefanie Cruschwitz; Rebecca A Riebe; Yinghua Zhang; Christopher H Morrell; David Browe; Yuan Chuan Lee; Rui-ping Xiao; Mark I Talan; Edward G Lakatta; Li Lin
Journal:  J Mol Med (Berl)       Date:  2013-10-17       Impact factor: 4.599

5.  Vessel ultrasound sonographic assessment of soluble receptor for advanced glycation end products efficacy in a rat balloon injury model.

Authors:  Hyun-Jin Tae; Natalia Petrashevskaya; Ismayil Ahmet; Sungha Park; Mark I Talan; Edward G Lakatta; Li Lin
Journal:  Curr Ther Res Clin Exp       Date:  2014-11-11

6.  Enhanced Endothelin A and B Receptor Expression and Receptor-Mediated Vasoconstriction in Rat Mesenteric arteries after Lipopolysaccharide Challenge.

Authors:  Wei Zhang; Shan-Shan Zhang; Hong-Lang Huang; Bing-Jie Song; Xiao Liu; Zhi Qi
Journal:  Mediators Inflamm       Date:  2019-11-14       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.